Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:appointed_by |
subcutaneous injection
|
| gptkbp:approves |
gptkb:1982
|
| gptkbp:developed_by |
gptkb:Genentech
E. coli or yeast |
| gptkbp:financial_performance |
room temperature
|
| https://www.w3.org/2000/01/rdf-schema#label |
recombinant human insulin
|
| gptkbp:influences |
fat storage
liver glucose production muscle glucose uptake |
| gptkbp:is |
often used in hospitals
subject to regulatory approval available in various formulations often used in combination with other diabetes medications a treatment that has transformed diabetes management available in both rapid-acting and long-acting forms a benchmark for other insulin products a biopharmaceutical a critical component of diabetes management a focus of pharmaceutical development a key advancement in diabetes treatment a key factor in diabetes research a life-saving medication for many patients a major innovation in endocrinology a medication that can be self-administered a peptide hormone a product of biotechnology a product of modern medicine a recombinant protein a significant advancement in diabetes care a standard treatment for diabetes a subject of ongoing clinical studies a synthetic form of insulin a treatment option for Type 1 diabetes a treatment option for Type 2 diabetes a treatment that can improve quality of life a treatment that requires careful dosing a widely prescribed medication administered to control hyperglycemia considered safe for use during pregnancy not derived from animal sources often monitored with blood glucose testing often used in conjunction with lifestyle changes produced by recombinant DNA technology used in insulin therapy a medication that can prevent diabetes-related complications a critical tool for managing diabetes complications |
| gptkbp:is_available_on |
pens
vials insulin pumps |
| gptkbp:is_compared_to |
animal insulin
|
| gptkbp:is_used_for |
treatment of diabetes
|
| gptkbp:marketed_as |
gptkb:Humulin
|
| gptkbp:produced_by |
gptkb:fungus
gptkb:physicist genetic engineering |
| gptkbp:regulates |
blood glucose levels
|
| gptkbp:requires |
prescription
|
| gptkbp:side_effect |
hypoglycemia
|
| gptkbp:type |
short-acting insulin
|
| gptkbp:weight |
5808 Da
|
| gptkbp:bfsParent |
gptkb:Humulin
|
| gptkbp:bfsLayer |
4
|